News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
391,452 Results
Type
Article (26754)
Company Profile (118)
Press Release (364580)
Section
Business (101892)
Career Advice (533)
Deals (17966)
Drug Delivery (79)
Drug Development (38683)
Employer Resources (78)
FDA (10689)
Job Trends (9966)
News (175107)
Policy (20599)
Tag
Academia (2102)
Alliances (28406)
Alzheimer's disease (826)
Approvals (10703)
Artificial intelligence (115)
Bankruptcy (144)
Best Places to Work (8956)
Biotechnology (64)
Breast cancer (108)
Cancer (707)
Cardiovascular disease (74)
Career advice (489)
Cell therapy (131)
Clinical research (31284)
Collaboration (308)
COVID-19 (2149)
C-suite (63)
Data (843)
Diabetes (118)
Diagnostics (4745)
Drug pricing (85)
Earnings (33196)
Employer resources (69)
Events (71303)
Executive appointments (263)
FDA (11185)
Funding (299)
Gene therapy (93)
GLP-1 (338)
Government (4073)
Healthcare (14894)
Infectious disease (2233)
Inflammatory bowel disease (75)
IPO (7651)
Job creations (1403)
Job search strategy (447)
Layoffs (154)
Legal (3886)
Lung cancer (94)
Manufacturing (120)
Medical device (9258)
Medtech (9261)
Mergers & acquisitions (10458)
Metabolic disorders (315)
Neuroscience (1008)
NextGen Class of 2024 (4969)
Non-profit (3917)
Northern California (976)
Obesity (188)
Opinion (107)
People (32123)
Phase I (9949)
Phase II (12263)
Phase III (11145)
Pipeline (297)
Policy (59)
Postmarket research (1573)
Preclinical (3157)
Radiopharmaceuticals (147)
Rare diseases (175)
Real estate (2833)
Regulatory (13648)
Research institute (1905)
Southern California (776)
Startups (2078)
United States (9428)
Vaccines (455)
Weight loss (118)
Date
Today (2)
Last 7 days (255)
Last 30 days (1470)
Last 365 days (21813)
2024 (21731)
2023 (24261)
2022 (33689)
2021 (37126)
2020 (37572)
2019 (33254)
2018 (24880)
2017 (17708)
2016 (18859)
2015 (21430)
2014 (16060)
2013 (12721)
2012 (13464)
2011 (13905)
2010 (11929)
Location
Africa (510)
Arizona (96)
Asia (21173)
Australia (3793)
California (2099)
Canada (953)
China (179)
Colorado (114)
Connecticut (138)
Europe (47203)
Florida (328)
Georgia (111)
Illinois (265)
Indiana (200)
Japan (65)
Kansas (72)
Maine (59)
Maryland (443)
Massachusetts (1699)
Michigan (112)
Minnesota (159)
New Jersey (784)
New York (689)
North Carolina (510)
Northern California (976)
Ohio (94)
Pennsylvania (613)
South America (670)
Southern California (776)
Texas (288)
Utah (89)
Washington State (279)
391,452 Results for "guardant health".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Biotech Bay
Guardant Health introduces new Guardant360 TissueNext test with nearly 500 biomarkers to identify more treatment options for patients with advanced cancer
Guardant Health, Inc., a leading precision oncology company, announced the launch of a new version of its Guardant360 TissueNext test that expands the number of genes it identifies in a tumor tissue sample to 498.
June 4, 2024
·
4 min read
Press Releases
Guardant Health Announces Collaboration With Boehringer Ingelheim to Develop Companion Diagnostic for Detection of Specific Mutations in Advanced Lung Cancer
December 18, 2024
·
3 min read
Biotech Bay
Guardant Health to Participate in Upcoming May 2024 Investor Conferences
Guardant Health, Inc., a leading precision oncology company, announced the company will participate in the following investor conferences.
May 7, 2024
·
1 min read
Biotech Bay
Guardant Health to Participate in Upcoming Investor Conferences - May 22, 2024
Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the company will participate in the following investor conferences.
May 22, 2024
·
1 min read
Press Releases
COTA and Guardant Health Partner to Advance Precision Oncology Research and Therapy Development with Real-World Clinicogenomic Data and AI Analytics
December 19, 2024
·
3 min read
Business
Guardant Health Named to TIME100 Most Influential Companies
Guardant Health, Inc. (NASDAQ:GH), a leading precision oncology company, today announced its inclusion in the fourth-annual TIME100 Most Influential Companies list, highlighting companies making an extraordinary impact around the world.
May 31, 2024
·
2 min read
Biotech Bay
Guardant Health Receives EU IVDR Certification for Guardant360® CDx Liquid Biopsy for Tumor Mutation Profiling Across All Solid Cancers and Companion Diagnostic Indications
Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced certification for its Guardant360® CDx blood test under the European Union’s In Vitro Diagnostic Regulation (IVDR 2017/746).
May 21, 2024
·
8 min read
Deals
Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced that on April 22, 2024, the Compensation Committee of Guardant’s Board of Directors approved the granting of restricted stock units (“RSUs”) representing 215,601 shares of its common stock to 94 new non-executive employees and non-qualified stock option awards to purchase an aggregate of 98,076 shares of its common stock to three new non-executive employees.
May 17, 2024
·
2 min read
Business
Guardant Health Reports First Quarter 2024 Financial Results and Increases 2024 Revenue Guidance
Guardant Health, Inc., a leading precision oncology company, reported financial results for the quarter ended March 31, 2024.
May 9, 2024
·
16 min read
Press Releases
Guardant Health Reports Third Quarter 2024 Financial Results and Increases 2024 Revenue Guidance
November 7, 2024
·
17 min read
1 of 39,146
Next
